PREDICTION METHOD FOR HETEROTOPIC OSSIFICATION DEVELOPMENT AFTER ENDOPROSTHESIS HIP JOINT REPLACEMENT

FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, particularly orthopedics, and can be applied to prevent heterotopic ossification (HO) development after endoprosthesis hip joint replacement. Method consists in C-reactive protein (CRP) and osteoprotegerine (OPG) levels determination in ve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ELFIMOV SERGEJ VIKTOROVICH, MAKAROVA EHMILIJA BORISOVNA, POLLJAK MIKHAIL NAUMOVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, particularly orthopedics, and can be applied to prevent heterotopic ossification (HO) development after endoprosthesis hip joint replacement. Method consists in C-reactive protein (CRP) and osteoprotegerine (OPG) levels determination in venous blood serum on 7th day after the operation. In case if one or both indices are equal or less than: CRP - 12 mg/l, OPG - 4.2 pmol/l, HO development possibility is predicted. Conduction of the method allows HO development prediction after endoprosthesis hip joint replacement in early postoperative period. ^ EFFECT: providing HO development prediction after endoprosthesis hip joint replacement in early postoperative period. ^ 2 tbl, 3 ex